{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-232025-03-232025-03-242025-03-242025-03-252025-03-252025-03-262025-03-262025-03-272025-03-272025-03-282025-03-2811112321323128866442200
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-232025-03-232025-03-242025-03-242025-03-252025-03-252025-03-262025-03-262025-03-272025-03-272025-03-282025-03-28111115421211118866442200
Download SVG
Download PNG
Download CSV

norges bank invests nearly two billion in citigroup shares

Norges Bank acquired 27,498,205 shares of Citigroup Inc. (NYSE:C) in Q4, valued at approximately $1.94 billion, holding about 1.45% of the company. Analysts have a consensus "Moderate Buy" rating, with price targets ranging from $79 to $95, as Citigroup's stock trades at $73.20, down 1.7%. The firm reported Q4 earnings of $1.34 EPS, exceeding estimates, with a revenue increase of 12.3% year-over-year.

wells fargo receives multiple price target increases from top analysts

Wells Fargo & Company has seen recent price target increases from several analysts, with Piper Sandler raising it to $75.00 and Goldman Sachs to $82.00, both maintaining positive ratings. The company has a consensus rating of "Moderate Buy" and a price target of $74.18, with significant institutional investment, holding 75.90% of shares. In its latest earnings report, Wells Fargo posted $1.43 earnings per share, exceeding estimates, while also announcing a quarterly dividend of $0.40.

goldman sachs outlines reasons fiscal policy won't offset tariff impacts

Goldman Sachs analysts assert that fiscal policy will struggle to mitigate the economic impact of new U.S. tariffs for three key reasons. Firstly, the timing of the proposed fiscal measures means they are unlikely to be implemented before the tariffs take effect. Secondly, the legislation is expected to primarily extend existing tax cuts with minimal new incentives. Lastly, potential risks such as a government shutdown and the need to raise the debt limit could further hinder economic growth.

Goldman Sachs maintains buy rating for Palo Alto Networks amid market uncertainties

Goldman Sachs has maintained a "buy" rating for Palo Alto Networks (PANW) with a target price of $215, citing the company's resilience in the cybersecurity sector despite macroeconomic uncertainties. While demand from the U.S. federal government has slowed, commercial demand remains stable, particularly in AI-related identity and data protection. Palo Alto's unique position as a U.S.-based firewall supplier may help it maintain profit margins amid tariff impacts, and the integration of its cloud business with the Cortex platform aims to address previous growth challenges.

wells fargo sees increased institutional investment and analyst price target upgrades

Wells Fargo & Company reported a 0.5% decline in quarterly revenue compared to the same period last year, with earnings per share at $1.43, surpassing estimates. The company announced a quarterly dividend of $0.40, yielding 2.18%, and has a moderate buy rating from analysts, with a consensus target price of $74.18.

Goldman Sachs upgrades UniCredit to buy with strong growth outlook

Goldman Sachs has reinstated coverage on UniCredit SpA, assigning a Buy rating with a price target of EUR 63.00, following a 44% rise in its shares in 2025, outperforming the European banking sector. Analysts expect strong fee income growth and effective cost control to enhance profitability, while UniCredit's return on tangible equity is projected to exceed 16%. The bank's valuation, now at approximately 8.9 times its 12-month forward P/E, aligns with sector peers, indicating a favorable outlook amidst a recovering European banking landscape.

GSK receives FDA approval for new antibiotic targeting urinary tract infections

GSK has received FDA approval for its new oral antibiotic, gepotidacin (Blujepa), aimed at treating uncomplicated urinary tract infections in women and adolescents. While the approval is a positive step for GSK's infectious disease portfolio, Goldman Sachs maintains a "neutral" rating, projecting modest sales growth for gepotidacin, with estimates falling short of market expectations. The drug addresses a significant need, as around 16 million women in the U.S. are affected by urinary tract infections annually.

Goldman Sachs upgrades Shell to buy with ambitious growth and return plans

Goldman Sachs has upgraded Shell (SHEL) to a "Buy" rating with a target price of $92, reflecting a 28% upside. The company plans to increase shareholder returns, aiming for 40-50% of cash flow, and will repurchase $14 billion in shares by 2025 while reducing capital expenditure guidance to $20-22 billion for 2025-28. Shell also targets a 10% increase in free cash flow per share by 2030 and aims to maintain steady oil production at 1.4 million barrels per day, all while adhering to its climate goals.

Goldman Sachs boosts Samvardhana Motherson shares with significant stake purchase

Samvardhana Motherson International's share price rose over 3% to ₹135.20 after Goldman Sachs acquired 65.48 lakh shares for ₹87 crore at an average price of ₹132.7. The company reported a consolidated net profit of ₹879 crore for Q3 FY25, up from ₹542 crore a year earlier, with total revenue increasing to ₹27,666 crore. Despite a 7% gain in the last month, the stock has declined 13.5% year-to-date but has risen 15% over the past year and delivered multibagger returns of 107% in two years.

nintendo shares rise as goldman predicts switch 2 will boost users

Nintendo shares surged over 6% in Tokyo, marking the largest gain in more than seven months, following Goldman Sachs' optimistic outlook on the upcoming Switch 2 console. The investment bank reinstated its coverage with a buy rating and set a 12-month price target of ¥13,600, indicating a potential 26% upside from the previous close.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.